230 related articles for article (PubMed ID: 20374200)
1. Thiazolidinedione treatment and constitutive-PPARgamma activation induces ectopic adipogenesis and promotes age-related thymic involution.
Youm YH; Yang H; Amin R; Smith SR; Leff T; Dixit VD
Aging Cell; 2010 Aug; 9(4):478-89. PubMed ID: 20374200
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution.
Yang H; Youm YH; Dixit VD
J Immunol; 2009 Sep; 183(5):3040-52. PubMed ID: 19648267
[TBL] [Abstract][Full Text] [Related]
3. Axin expression in thymic stromal cells contributes to an age-related increase in thymic adiposity and is associated with reduced thymopoiesis independently of ghrelin signaling.
Yang H; Youm YH; Sun Y; Rim JS; Galbán CJ; Vandanmagsar B; Dixit VD
J Leukoc Biol; 2009 Jun; 85(6):928-38. PubMed ID: 19299626
[TBL] [Abstract][Full Text] [Related]
4. Organotins are potent activators of PPARγ and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells.
Yanik SC; Baker AH; Mann KK; Schlezinger JJ
Toxicol Sci; 2011 Aug; 122(2):476-88. PubMed ID: 21622945
[TBL] [Abstract][Full Text] [Related]
5. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.
Li Y; Wang Z; Furukawa N; Escaron P; Weiszmann J; Lee G; Lindstrom M; Liu J; Liu X; Xu H; Plotnikova O; Prasad V; Walker N; Learned RM; Chen JL
J Biol Chem; 2008 Apr; 283(14):9168-76. PubMed ID: 18263587
[TBL] [Abstract][Full Text] [Related]
6. Obesity accelerates thymic aging.
Yang H; Youm YH; Vandanmagsar B; Rood J; Kumar KG; Butler AA; Dixit VD
Blood; 2009 Oct; 114(18):3803-12. PubMed ID: 19721009
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980.
Jung H; Lee MS; Jang EJ; Ahn JH; Kang NS; Yoo SE; Bae MA; Hong JH; Hwang ES
Biochem Pharmacol; 2009 Nov; 78(10):1323-9. PubMed ID: 19591806
[TBL] [Abstract][Full Text] [Related]
9. The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.
Hasegawa T; Oizumi K; Yoshiko Y; Tanne K; Maeda N; Aubin JE
BMC Dev Biol; 2008 Jul; 8():71. PubMed ID: 18625072
[TBL] [Abstract][Full Text] [Related]
10. Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells.
Tan J; Wang Y; Wang S; Wu S; Yuan Z; Zhu X
Cell Biosci; 2019; 9():48. PubMed ID: 31249661
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2.
Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS
J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620
[TBL] [Abstract][Full Text] [Related]
12. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).
Stechschulte LA; Ge C; Hinds TD; Sanchez ER; Franceschi RT; Lecka-Czernik B
J Biol Chem; 2016 Nov; 291(47):24475-24486. PubMed ID: 27687725
[TBL] [Abstract][Full Text] [Related]
13. Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity.
Youm YH; Yang H; Sun Y; Smith RG; Manley NR; Vandanmagsar B; Dixit VD
J Biol Chem; 2009 Mar; 284(11):7068-77. PubMed ID: 19054770
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone Promotes Bone Marrow Adipogenesis to Impair Myelopoiesis under Stress.
Lu W; Wang W; Wang S; Feng Y; Liu K
PLoS One; 2016; 11(2):e0149543. PubMed ID: 26895498
[TBL] [Abstract][Full Text] [Related]
15. Notch1 Inhibits Rosiglitazone-Induced Adipogenic Differentiation in Primary Thymic Stromal Cells.
Wang Y; Tan J; Du H; Liu X; Wang S; Wu S; Yuan Z; Zhu X
Front Pharmacol; 2018; 9():1284. PubMed ID: 30483127
[TBL] [Abstract][Full Text] [Related]
16. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
Takasawa K; Kubota N; Terauchi Y; Kadowaki T
Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
[TBL] [Abstract][Full Text] [Related]
17. Mechanical input restrains PPARγ2 expression and action to preserve mesenchymal stem cell multipotentiality.
Case N; Thomas J; Xie Z; Sen B; Styner M; Rowe D; Rubin J
Bone; 2013 Jan; 52(1):454-64. PubMed ID: 22951341
[TBL] [Abstract][Full Text] [Related]
18. An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.
Fukunaga T; Zou W; Rohatgi N; Colca JR; Teitelbaum SL
J Bone Miner Res; 2015 Mar; 30(3):481-8. PubMed ID: 25257948
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 administration to aged mice rejuvenates their peripheral T-cell pool by triggering de novo thymopoiesis.
Al-Chami E; Tormo A; Pasquin S; Kanjarawi R; Ziouani S; Rafei M
Aging Cell; 2016 Apr; 15(2):349-60. PubMed ID: 26762709
[TBL] [Abstract][Full Text] [Related]
20. Tributyltin induces a transcriptional response without a brite adipocyte signature in adipocyte models.
Kim S; Li A; Monti S; Schlezinger JJ
Arch Toxicol; 2018 Sep; 92(9):2859-2874. PubMed ID: 30027469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
